Affordable Access

Access to the full text

ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status

Authors
  • barés, gisel
  • beà, aida
  • hernández, luís
  • navaridas, raul
  • felip, isidre
  • megino, cristina
  • blasco, natividad
  • nadeu, ferran
  • campo, elías
  • llovera, marta
  • dolcet, xavier
  • sanchis, daniel
Publication Date
Jul 28, 2021
Identifiers
DOI: 10.3390/cancers13153803
OAI: oai:mdpi.com:/2072-6694/13/15/3803/
Source
MDPI
Keywords
Language
English
License
Green
External links

Abstract

EndoG influences mitochondrial DNA replication and is involved in somatic cell proliferation. Here, we investigated the effect of ENDOG/Endog expression on proliferation in different tumor models. Noteworthy, ENDOG deficiency reduced proliferation of endometrial tumor cells expressing low PTEN/high p-AKT levels, and Endog deletion blunted the growth of PTEN-deficient 3D endometrial cultures. Furthermore, ENDOG silencing reduced proliferation of follicular thyroid carcinoma and glioblastoma cell lines with high p-AKT expression. High ENDOG expression was associated with a short time to treatment in a cohort of patients with chronic lymphocytic leukemia (CLL), a B-cell lymphoid neoplasm with activation of PI3K/AKT. This clinical impact was observed in the less aggressive CLL subtype with mutated IGHV in which high ENDOG and low PTEN levels were associated with worse outcome. In summary, our results show that reducing ENDOG expression hinders growth of some tumors characterized by low PTEN activity and high p-AKT expression and that ENDOG has prognostic value for some cancer types.

Report this publication

Statistics

Seen <100 times